I think it reinforces the ongoing communication that the FDA is having with NWBO. An imaging biomarker would be perfect for this trial since they use the MRI so often. If it is a reliable biomarker I can see NWBO approval being expedited. Things are certainly moving differently for NWBO. I cheer NWBO on sometimes, but not very often.